People · Operator

Adam J. Chill

Named in public records as an officer, director or promoter · active 2014–2024 · Biotechnology, Other Health Care

2
Companies
3
Filings
$105.1M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Mustang Bio, Inc.BiotechnologySeries C$102.3M$22.7M2023
CB Pharma Acquisition Corp.Other Health CareSeed$2.9M$70.6M2014
Operator network

Adam J. Chill at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Lindsay A. Rosenwald, M.D. · 3 companies · 1 sharedLindsay A. Rosenw…James B. Murphy · 2 companies · 1 sharedJames B. MurphyEliot S. Lurier · 1 companies · 1 sharedEliot S. LurierManuel B. Litchman, M.D. · 1 companies · 1 sharedManuel B. Litchma…Manuel S. Litchman, M.D. · 1 companies · 1 sharedManuel S. Litchma…Michael J. Zelefsky, M.D. · 1 companies · 1 sharedMichael J. Zelefs…Lindsay A. Rosenwald · 7 companies · 2 sharedLindsay A. Rosenw…Michael S. Weiss · 7 companies · 2 sharedMichael S. WeissNeil A. Herskowitz · 4 companies · 2 sharedNeil A. HerskowitzArthur A. Kornbluth · 1 companies · 1 sharedArthur A. Kornblu…George C. Avgerinos · 1 companies · 1 sharedGeorge C. Avgerin…Mustang Bio, Inc. · $102.3M raisedMustang Bio, Inc.CB Pharma Acquisition Corp. · $2.9M raisedCB Pharma Acquisition…Adam J. ChillAC
Adam J. Chill Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Adam J. Chill on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Michael S. Weiss27
Lindsay A. Rosenwald27
Neil A. Herskowitz24
Lindsay A. Rosenwald, M.D.13
James B. Murphy12
Manuel S. Litchman, M.D.11
Eliot S. Lurier11
George C. Avgerinos11
Arthur A. Kornbluth11
Manuel B. Litchman, M.D.11
Michael J. Zelefsky, M.D.11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.